Trial Search Results
Insulin Resistance in Patients With Major Depression
The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.
Stanford is currently not accepting patients for this trial.
Collaborator: American Diabetes Association
Inclusion Criteria:1)Willingness to sign the Human Subject Protection Consent Form prior to
enrollment into the study.
2)Men and women ages 20 to 65 years of age. 3)Diagnosis of unipolar, non-psychotic,
non-melancholic major depressive disorder (MDD) or depressive episode of bipolar disorder
(Bipolar I, II or NOS), based on a Structured Clinical Interview for DSM-IV Axis I
disorders (SCID) and confirmed by a psychiatrist.
4) Depression severity as defined by score of <17 on the 21-item Hamilton Rating Scale for
Depression and no psychiatric admission within 6 months from study entry and no suicide
attempt within the last 12 months.
5)Adequate visual and auditory acuity to allow neuropsychological testing. 6)Stable regime
of psychiatric medications for 1 month prior to insulin test. Exclusion
Criteria:1)Diagnosis of possible or probable cognitive impairment.
2)For women only: pregnancy, breastfeeding. 3)Personal history of Type I or Type II
diabetes. 4) Unstable cardiovascular disease or other major medical condition, or history
of myocardial infarction within the previous year.
5)Significant cerebrovascular disease, as evidenced by neurological examination,
uncontrolled hypertension (systolic blood pressure > 170 or diastolic blood pressures >
6) Current drug or alcohol abuse. 7)History of neurological disorder, e.g. multiple
sclerosis, stroke etc. 8)Use of any drug that may significantly affect psychometric
testing, or the insulin testing
Ages Eligible for Study
20 Years - 65 Years
Genders Eligible for Study